Therapeutic Options and Cost-Effectiveness for Rheumatoid Arthritis Treatment

被引：0
|
作者：
Alexandros A. Drosos
Eleftherios Pelechas
Evripidis Kaltsonoudis
Paraskevi V. Voulgari
机构：
[1] University of Ioannina,Rheumatology Clinic, Department of Internal Medicine, Medical School
来源：
Current Rheumatology Reports | 2020年 / 22卷
关键词：
csDMARDs; bDMARDs; Triple therapy; Cost-effectiveness; Work productivity; Quality of life;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Cost-effectiveness of infliximab for rheumatoid arthritis in Spain
    Wong, JB
    Ballina, J
    Fernandez-Sueiro, J
    Garcia-Vadillo, J
    Gonzalez-Fernandez, C
    Gonzalez-Crespo, M
    Gratacos, J
    Ivorra, J
    Navarro-Sarabia, F
    Tornero, J
    Casado, MA
    Fosbrook, L
    Pocovi, A
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 520 - 521
  • [22] COST-EFFECTIVENESS OF ADALIMUMAB FOR RHEUMATOID ARTHRITIS IN GERMANY
    Gissel, C.
    VALUE IN HEALTH, 2014, 17 (03) : A48 - A48
  • [23] Cost-effectiveness of adalimumab for rheumatoid arthritis in Germany
    Gissel, C.
    Goetz, G.
    Repp, H.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2016, 75 (10): : 1006 - 1015
  • [24] Cost-Effectiveness of Biologics in Early Rheumatoid Arthritis
    Finckh, Axel
    Bansback, Nick
    Liang, Matthew H.
    ANNALS OF INTERNAL MEDICINE, 2010, 152 (05) : 333 - 334
  • [25] VALIDATION OF A COST-EFFECTIVENESS MODEL IN RHEUMATOID ARTHRITIS
    Sadler, S.
    Jacob, I
    Darlington, O.
    Still, E.
    Gordon, J.
    Radford, M.
    Gharaibeh, M.
    VALUE IN HEALTH, 2020, 23 : S595 - S595
  • [26] Cost-effectiveness of TNF-α-blocking agents in the treatment of rheumatoid arthritis
    Merkesdal, S
    Ruof, J
    Mittendorf, T
    Zeidler, H
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (09) : 1881 - 1886
  • [27] Cost-effectiveness treatment with Rituximab in patients with rheumatoid arthritis in real life
    Benucci, Maurizio
    Saviola, Gianantonio
    Baiardi, Paola
    Manfredi, Mariangela
    RHEUMATOLOGY INTERNATIONAL, 2011, 31 (11) : 1465 - 1469
  • [28] ABATACEPT FOR THE TREATMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS IN ARGENTINA: A COST-EFFECTIVENESS ANALYSIS
    Elgart, J. F.
    Gonzalez, L.
    Aiello, E. C.
    VALUE IN HEALTH, 2013, 16 (03) : A223 - A224
  • [29] Cost-effectiveness of rituximab as a new treatment modality for rheumatoid arthritis in Germany
    Rubbert, A
    Kielhorn, A
    Schach, S
    Brown, B
    Aristides, M
    VALUE IN HEALTH, 2006, 9 (03) : A25 - A25
  • [30] Cost-effectiveness treatment with Rituximab in patients with rheumatoid arthritis in real life
    Maurizio Benucci
    Gianantonio Saviola
    Paola Baiardi
    Mariangela Manfredi
    Rheumatology International, 2011, 31 : 1465 - 1469
12345